SEC 13F Intelligence

Almitas Capital LLC / DSGN

Almitas Capital LLC’s Design Therapeutics Inc Position

Does Almitas Capital LLC own Design Therapeutics Inc (DSGN)? Yes — 1.53M shares worth $16M (+3.68% of its 13F portfolio) as of Q1 2026, down from 1.53M shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
1.53M
% of Portfolio
+3.68%
Quarters Held
10
currently held

Position History DSGN

Reported value by quarter
Q4 ’23: $3MQ4 ’23Q1 ’24: $4MQ2 ’24: $4MQ2 ’24Q3 ’24: $7MQ4 ’24: $8MQ4 ’24Q1 ’25: $6MQ2 ’25: $5MQ2 ’25Q3 ’25: $23MQ4 ’25: $14MQ4 ’25Q1 ’26: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.53M$16M+3.68%
Q4 20251.53M$14M+3.16%
Q3 20253.06M$23M+2.66%
Q2 20251.53M$5M+1.30%
Q1 20251.45M$6M+1.86%
Q4 20241.32M$8M+1.79%
Q3 20241.32M$7M+2.52%
Q2 20241.25M$4M+1.75%
Q1 20241.03M$4M+1.71%
Q4 20231.03M$3M+0.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Almitas Capital LLC’s full portfolio or all institutional holders of DSGN.